The Hydrocephalus Shunt Market in 2026 is investing heavily in infection prevention technologies, as shunt infection remains the most clinically serious and economically costly complication of cerebrospinal fluid diversion therapy, requiring complete shunt system removal, external ventricular drainage, prolonged antibiotic therapy, and subsequent shunt reimplantation in a process that exposes...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek